Waverley Pharma Inc. is a specialty pharma company that is dedicated to the development and commercialization of safe, effective and affordable cancer therapeutics. The company’s current focus is on the generic oncology injectable market in the European Union and North America. The company has two lead products ready for regulatory filing, and is currently developing a pipeline of injectable products, through multiple partnerships, in different stages of development. Waverley Pharma is committed to providing patients with affordable prescription medicines that lower healthcare costs and provide a better quality of life.